Dennis A. Ausiello, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 15,000 shares at $110.00 ($1.6M) on 2014-12-08, disclosed to the SEC on 2014-12-10.
Scheduled sale ($1.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.00 | 5,000 | $525K | 32.3% |
| 2 | $110.00 | 10,000 | $1.1M | 67.7% |
| Total | $108.33 avg | 15,000 | $1.6M | 100% |
| Filing → |
| ALNY | SELL | 2022-11-23 | $5.0M | — | Filing → |
| ALNY | SELL | 2018-03-14 | $2.6M | — | Filing → |
| ALNY | SELL | 2017-11-03 | $2.6M | — | Filing → |